Lung cancer in solid organ transplant recipients
Lung cancer remains the leading cause of cancer mortality worldwide. Solid organ transplant recipients are at risk of developing malignant tumors, including lung cancer, due to long-term use of immunosuppressive drugs. Development of cancer, including lung cancer, in this patient cohort, has a numbe...
Main Authors: | A. V. Nikulin, I. V. Pashkov, Ya. S. Yakunin |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Federal Research Center of Transplantology and Artificial Organs named after V.I.Shumakov
2022-01-01
|
Series: | Vestnik Transplantologii i Iskusstvennyh Organov |
Subjects: | |
Online Access: | https://journal.transpl.ru/vtio/article/view/1407 |
Similar Items
-
Post-transplant malignancies in solid organ recipients: development mechanisms and risk factors
by: A. V. Nikulin, et al.
Published: (2021-09-01) -
Prevention and Management of Infections in Lung Transplant Recipients
by: Anum Fayyaz, et al.
Published: (2023-12-01) -
Сlinical features of malignant tumors against the background of immunosuppressive therapy in heart transplant recipients
by: L. B. Krougly, et al.
Published: (2021-07-01) -
COVID-19 Outcomes and Vaccinations in Swedish Solid Organ Transplant Recipients 2020–2021: A Nationwide Multi-Register Comparative Cohort Study
by: John Mackay Søfteland, et al.
Published: (2024-02-01) -
Current Perspectives on the Management of Herpesvirus Infections in Solid Organ Transplant Recipients
by: S. Reshwan K. Malahe, et al.
Published: (2023-07-01)